Burixafor hydrobromide - CAS 1191450-19-7

Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist with anti-angiogenic properties, potentially valuable in treating choroid neovascularization.

VEGFR, CXCR

Autophagy, Tyrosine Kinase/Adaptors, Immunology/Inflammation, GPCR/G Protein, Angiogenesis

1191424

C27H52BrN8O3P

647.644

Br.Nc1cc(nc(NCC2CCC(CNCCCNC3CCCCC3)CC2)n1)N1CCN(CCP(O)(O)=O)CC1

-20°C

Ice Packs

Small Compound